Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: Phase II study
- 1 November 2005
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 50 (2), 247-254
- https://doi.org/10.1016/j.lungcan.2005.05.026
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cognitive sequelae of brain radiation in adultsSeminars in Oncology, 2004
- Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III studyInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Stereotactic radiosurgery with whole brain radiation therapy improves survival in patients with brain metastases: report of radiation therapy oncology group phase III study 95–08International Journal of Radiation Oncology*Biology*Physics, 2002
- First-Line Chemotherapy with Vinorelbine, Gemcitabine, and Carboplatin in the Treatment of Brain Metastases from Non-Small-Cell Lung Cancer: A Phase II StudyCancer Investigation, 2002
- Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancerLung Cancer, 1999
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology*Biology*Physics, 1997
- The choice of treatment of single brain metastasis should be based on extracranial tumor activity and ageInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumoursEuropean Journal Of Cancer, 1993
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990
- Radiation‐induced dementia in patients cured of brain metastasesNeurology, 1989